1. Home
  2. EVLV vs QURE Comparison

EVLV vs QURE Comparison

Compare EVLV & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolv Technologies Holdings Inc.

EVLV

Evolv Technologies Holdings Inc.

HOLD

Current Price

$7.09

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$29.00

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVLV
QURE
Founded
2013
1998
Country
United States
Netherlands
Employees
N/A
248
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
EVLV
QURE
Price
$7.09
$29.00
Analyst Decision
Strong Buy
Buy
Analyst Count
4
14
Target Price
$9.13
$45.00
AVG Volume (30 Days)
2.1M
1.8M
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.67
EPS
N/A
N/A
Revenue
N/A
$13,107,000.00
Revenue This Year
$21.67
$126.12
Revenue Next Year
$19.50
$200.43
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.61
$8.73
52 Week High
$8.90
$71.50

Technical Indicators

Market Signals
Indicator
EVLV
QURE
Relative Strength Index (RSI) 60.05 79.84
Support Level $6.42 $21.16
Resistance Level $7.46 $60.70
Average True Range (ATR) 0.26 2.04
MACD -0.03 1.12
Stochastic Oscillator 60.95 94.18

Price Performance

Historical Comparison
EVLV
QURE

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: